知镜 Cognispect · 医学文献与研究工作台

Obesity and Diabetes Increase SARS-CoV-2 Susceptibility Through Angiotensin-Converting Enzyme 2, Immunologic, and Gut Microbial Dysregulation.

Gheblawi M, Khoramjoo M, Elaish M, Wang K, Puttagunta L, Wang F, Zhabyeyev P, Ogando NS, Basu R, Zhang A, Colombo D, Del Nonno F, Girardi E, De Gaspari M, Basso C, Chiu B, Mlaga KD, John R, Scholey JW, Tan Q, Prasad R, Wright JR, Lamendella R, Power C, Evans DH, Falcone EL, Noyce RS, Penninger JM, Kassiri Z, Hobman TC, Grant MB, Oudit GY.
JACC. Basic to translational science · 2026-10-01 · PMID 42937414

文献摘要

Angiotensin-converting enzyme 2 (ACE2), the receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is ubiquitously expressed and contributes to cardiovascular, metabolic, and gastrointestinal homeostasis. In this study, we observed ACE2 loss in organs of patients with COVID-19 and in SARS-CoV-2-infected cells. In aged, obese, and diabetic mice, SARS-CoV-2 infection caused greater morbidity, persistent pulmonary infection, intestinal and metabolic disruption, and impaired cardiac Wnt and interferon-γ signaling. ACE2-deficient obese-diabetic mice showed cardiovascular, intestinal, metabolic, and neurobehavioral abnormalities, providing a complementary model to examine ACE2-associated disruption in metabolic disease. Exploratory metabolic profiling identified shared disruptions in taurine, tryptophan, and microbiota-derived metabolites across clinical and preclinical samples. These findings identify metabolic disease as a modifier of SARS-CoV-2 susceptibility and support ACE2-associated dysregulation as one contributor to selected infection-related sequelae.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。